Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F03%3A00008913" target="_blank" >RIV/00216224:14110/03:00008913 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Olanzapine versus risperidone in first-episode schizophrenic and schizophorm disorders:a double-blind comparison
Original language description
In double-blind randomized trial olanzapine was more suitable antipsychotic for the treatment of first-episode psychoses for the greater final improvement, better reduction of negative symptoms a fewer extrapyramidal side -effects and hyperprolactinemiathan risperidone
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FL - Psychiatry, sexology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2003
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Neuropsychopharmacology
ISSN
0924-977X
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
Suppl.4
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
1
Pages from-to
"S291"
UT code for WoS article
—
EID of the result in the Scopus database
—